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Editorial
Dear readers of the Journal of Negative Results in Biomedi-
cine,
We are pleased to introduce you to the Journal of Negative
Results in Biomedicine (JNRBM). A journal, very unique
in its kind, as it publishes articles, fully PubMed indexed
that challenge current models, tenets and dogmas. The ar-
ticles are based on rigorous, and well documented results
that do not support these models or even disprove them.
It publishes methods and techniques that are found to be
unsuitable for studying a particular phenomenon. JNRBM
strongly promotes and encourages the publication of clin-
ical trials that fall short of demonstrating an improvement
over current treatments. JNRBM's immediate goal is to
provide scientists and physicians with responsible and
balanced information in order to improve experimental
designs and clinical decisions.
As we started this journal we received a large amount of
positive feedback, as well as some critical comments and
questions. Among them, why such a journal? What are the
benefits of a journal that publishes negative results? Won't
such published information give my competitors an ad-
vantage? How do you avoid publishing bad science?
To respond to these concerns, we would like to draw the
reader's attention to Karl Popper's realization that science
advances through a process of "conjectures and refuta-
tions". Popper gave a rather compelling and simple exam-
ple: For thousands of years Europeans believed that swans
are white based on observations of millions of white
swans, until exploration of Australasia introduced Euro-
peans to black swans. Popper's point: Only one black
swan was needed to repudiate the theory that all swans are
white. However many confirming instances there are for a
theory, it only takes one counter observation to falsify it.
As compelling as Popper's arguments are, in reality how-
ever, scientists with controversial results, results that re-
fute a current model or "negative" results struggle for their
acknowledgement. Numerous examples of scientists can
be given where these kind of findings went unnoticed or
worse, were ridiculed, to only have their groundbreaking
discoveries confirmed decades later. One such example is
Gregor Mendel who painstakingly gathered data from
hundreds of crosses of his pea plants and deduced what he
called the First and Second Laws of Heredity. He further
formulated a simple model by which these laws could op-
erate and proposed that observed traits are determined by
discrete "factors," now called genes.
Mendel's work, presented to various authorities and soci-
eties in 1865–1867 was all but ignored by his colleagues
and authorities because it challenged the contemporary
theory of blending of inherited traits. Years later, copies of
his manuscript were found unopened among the papers
of some of his prominent colleagues. It was not until
1902, when Hugo de Vries, Carl Correns and Erich von
Tschermak rediscovered the principles formulated by
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Mendel, that the branch of biology known as genetics was
launched.
Not every unexpected set of observations and controver-
sial conclusion or proposed model will turn out to be of
mendelian significance or even confirmed by subsequent
scientific progress. However, we strongly believe that such
observations and conclusions that are based on rigorous
experimentation and thorough documentation, ought to
be published in order to be discussed, confirmed or refut-
ed by others. If in the end the "negative results" are the
consequence of some fundamental flaw in methods that
are commonly used, perhaps further analysis by others
may help uncover those flaws and lead to a methodolog-
ical improvement. If the "negative results" originate from
deficiencies in reagents commonly used, or deficiencies
that only emerge in a particular experimental situation,
publication of such results may lead to a reassessment of
the properties of such reagents. Common examples are
the reassessment of antibody specificity, the origin of a
cell line, or the sequence of a DNA probe.
Finally, we believe it is useful and important to publish
well documented failures, such as with drugs that show no
benefit or clinical improvement, as well as with the use of
methods that are unreliable but for which the shortcom-
ings have not been publicized.
Bjorn Olsen MD PhD
Christian Pfeffer MD
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